Apr 7, 2022 ProMIS Files Management Information Circular in Connection with Annual General and Special Meeting of Shareholders
Mar 24, 2022 ProMIS Neurosciences to Present at the 10th Annual Neurodegenerative Drug Development Summit
Mar 22, 2022 ProMIS Neurosciences Presents Preclinical Results of its Experimental Alzheimer’s Vaccine at the 2022 International AD/PDTM Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
Mar 10, 2022 ProMIS Neurosciences to Present at the 2022 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PDTM) and Related Neurological Disorders
Mar 2, 2022 ProMIS Neurosciences’ PMN310 antibody demonstrates significant cognitive benefit in a mouse model of Alzheimer’s disease
Feb 3, 2022 ProMIS Neurosciences Appoints Renowned Neuroscientists, Dr. Guy Rouleau and Dr. Alain Dagher to its Scientific Advisory Board
Jan 27, 2022 ProMIS Neurosciences Appoints Internationally Recognized Neuroscientist Dr. Cheryl Wellington to its Scientific Advisory Board